Struggling health and wellness firm Ascendis Health, whose share price has lost more than a third of its value in 2020, said on Wednesday that it has been given a revenue boost by Cyprus-based Remedica, which it is still considering selling. 

The group is grappling with a hefty debt burden, with its liabilities of R8.6bn as of the end of June exceeding its assets by R400m, an insufficient solvency ratio.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now